PBH Financials

Income Statement
MetricQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026
Revenue
265.7M
-5.6%
281.6M
-0.6%
283.4M
+3.4%
274.1M
+9.9%
249.5M
Cost of Revenue
129.5M
-4.3%
135.3M
+7.3%
126.1M
+2.9%
122.5M
+12.2%
109.2M
Gross Profit
136.2M
-6.9%
146.3M
-7.0%
157.4M
+3.8%
151.6M
+8.0%
140.3M
Operating Expenses
83.7M
+18.2%
70.8M
-5.4%
74.9M
+4.1%
71.9M
+4.9%
68.6M
R&D
0
0
0
0
0
SG&A
78.0M
+19.3%
65.4M
-6.3%
69.7M
+4.5%
66.7M
+5.3%
63.4M
Operating Income
52.5M
-30.4%
75.5M
-8.5%
82.5M
+3.5%
79.7M
+11.0%
71.8M
EBITDA
61.3M
-26.9%
83.8M
-6.9%
90.1M
+3.1%
87.3M
+10.0%
79.4M
Net Income
29.2M
-45.9%
53.9M
+15.5%
46.7M
+10.6%
42.2M
-11.1%
47.5M
EPS (Basic)
$0.61
-46.5%
$1.14
+16.3%
$0.98
+14.0%
$0.86
-10.4%
$0.96
EPS (Diluted)
$0.61
-46.0%
$1.13
+16.5%
$0.97
+12.8%
$0.86
-9.5%
$0.95
Shares (Diluted)
47.6M
-0.2%
47.7M
-0.8%
48.1M
-2.4%
49.3M
-1.1%
49.8M
Prestige Consumer Healthcare (PBH) โ€” Financials